Figure 1: Actuarial Survival patients with esophagogastric adenocarcinoma after preoperative chemotherapy (CTX) and surgical resection with versus without postoperative CTX. a. 70 patients with favourable histopathological response (= 50 % vital tumor cells). Pre-and postoperative CTX n=50, postoperative CTX only n=20; b. 64 patients with poor histopathological response (> 50 % vital tumor cells). Pre-and postoperative CTX n=36, postoperative CTX only n=28; c. 78 nodal negative patients. Pre-and postoperative CTX n=53, postoperative CTX only n= n=25; d. 56 nodal positive patients. Pre-and postoperative CTX n=33, postoperative CTX only n=23.